Baillie Gifford & Co
QTTB icon

Baillie Gifford & Co’s Q32 Bio QTTB Stock Holding History

Baillie Gifford & Co’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-27
Closed -$1K – 498
2022
Q2 		$1K Hold
27
– – ﹤0.01% 486
2022
Q1 		$1K Hold
27
– – ﹤0.01% 494
2021
Q4 		$2K Hold
27
– – ﹤0.01% 495
2021
Q3 		$4K Hold
27
– – ﹤0.01% 484
2021
Q2 		$3K Hold
27
– – ﹤0.01% 466
2021
Q1 		$5K Hold
27
– – ﹤0.01% 436
2020
Q4 		$5K Buy
+27
New +$5.22K ﹤0.01% 417

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co's QTTB Position: Q3 2022 in Review

Baillie Gifford & Co sold out of Q32 Bio (QTTB) in Q3 2022, closing a stake of 27 shares — an estimated $1K sold.

Baillie Gifford & Co first reported a position in QTTB in Q4 2020 and held it in 7 quarters. The position peaked at $5K in Q1 2021. 83 funds tracked by Wall St. Rank hold QTTB as of Q3 2022.

  • Baillie Gifford & Co reported no remaining Q32 Bio position as of Q3 2022 after selling out during the quarter.
  • Baillie Gifford & Co sold 27 Q32 Bio shares in Q3 2022, an estimated $1K.
  • Baillie Gifford & Co first reported a position in Q32 Bio in Q4 2020 and held it in 7 quarters.
  • Baillie Gifford & Co's Q32 Bio position peaked at $5K in Q1 2021.
  • 83 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2022.

Based on Baillie Gifford & Co's 13F filing for Q3 2022, filed 27 Oct 2022.